AMAG Pharmaceuticals Faces Securities Class Action

On March 18, 2010, a class action lawsuit was filed in the United States District Court for the District of Massachusetts against AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG). The complaint alleges violations of federal securities laws, specifically Section 11 of the Securities Exchange Act of 1934, including allegations of issuing a series of material misrepresentations to the market which had the effect of artificially inflating the market price on or about the date of the Registration Statement, January 21, 2010.

Plaintiff seeks to recover damages on behalf of the Class. If you are a member of the Class as described above, you may move the Court no later than Tuesday, May 18, 2010, to serve as a lead plaintiff for the Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.

AMAG Pharmaceuticals Securities Class Action Legal Help

If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Please click here for a free evaluation of your secutiries case

Last updated on Mar-23-10

SECUTIRIES LEGAL HELP NOW!

Please complete this form to request a review of your complaint by an attorney.

First name:

Last name:

Email address:

Phone number(s):

State:

Zip Code:

Defendant:

Describe your complaint:

Subscribe to our free newsletter

There is absolutely no cost to you to submit this form. Doing so places you under no obligations and does not establish an attorney-client relationship.

secutiries Legal Help Now!

CLICK HERE

Related Lawsuits

Legal Services: